Sabesan Yoganathan
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 14, 2025
N,N-Diethylacetamide and N,N-Dipropylacetamide inhibit the NF-kB pathway in in vitro, ex vivo and in vivo models of inflammation-induced preterm birth.Samir Gorasiya, Juliet Mushi, Sabesan Yoganathan
|Apr 10, 2024
Chemical Derivatization Leads to the Discovery Of Novel Analogs of Azotochelin, a Natural Siderophore, as Promising Anticancer Agents.Nishant M Karadkhelkar, Pranav Gupta, Leonard Barasa
|May 13, 2022
An efficient one-pot conversion of carboxylic acids into benzimidazoles <i>via</i> an HBTU-promoted methodology.Leonard Barasa, Sabesan Yoganathan
|Mar 06, 2021
Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer.Sabesan Yoganathan, Anushan Alagaratnam, Nikita Acharekar
|Oct 05, 2019
Chemical Space Exploration around Thieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one Scaffold Led to a Novel Class of Highly Active <i>Clostridium difficile</i> Inhibitors.Xuwei Shao, Ahmed AbdelKhalek, Nader S Abutaleb
|Aug 28, 2019
Development of an Arginine Anchored Nanoglobule with Retrograde Trafficking Inhibitor (Retro-2) for the Treatment of an Enterohemorrhagic <i>Escherichia coli</i> Outbreak.Tasneem Gandhi, Manali Patki, Jing Kong
Pageof 2
